Biotechnology Current Affairs

Union Government launches National Biopharma Mission

The Union Ministry of Science & Technology has launched National Biopharma Mission, a first ever Industry-Academia mission to accelerate biopharmaceutical development in India.

Under this mission, the ministry also launched Innovate in India (i3) program to create an enabling ecosystem to promote entrepreneurship and indigenous manufacturing in the sector.


India has been an active player in the global pharmaceutical industry and has contributed towards making life saving drugs and low cost pharmaceutical products accessible at affordable rates. Despite, these advances, Indian biopharmaceutical industry is still 10-15 years behind their counterparts in the developed countries and faces stiff competition from Korea, China and others.

The lacuna primarily exists due to disconnected centers of excellence, less focus on translational research and uncertain funding. So there was an immediate need to consolidated efforts to promote product discovery, translational research and early stage manufacturing in the country to ensure inclusive innovation.

About Innovate in India (i3) program

i3 is a flagship program of the Government of India in collaboration with World Bank. It is committed to make India a hub for design and development of novel, affordable and effective biopharmaceutical products and solutions.

It promises to boost the growth of domestic biopharma industry by accelerating the translation of research concepts into viable products and supporting clinical validation. Moreover it will enable sustainable networks for collaboration between industry and academia, and support entrepreneurial ecosystem.

The program will witness an investment of $250 million with $125 million as a loan from world Bank.  It will strive to increase India’s global biopharmaceutical market share from current 2.8% to 5% and generate additional business opportunity of $16 billion. The program will help to innovate, co-create and co-facilitate scientific discoveries and offer young entrepreneurs an avenue to engage with the best in the industry.

About National Biopharma Mission

The mission aims to enable and nurture an ecosystem for preparing India’s technological and product development capabilities in biopharmaceuticals to be globally competitive level over the next decade. It will also strive to transform the health standards of India’s population through affordable product development

The mission will be implemented by Biotechnology Industry Research Assistance Council (BIRAC), a PSU of Department of Biotechnology. It will bring together expertise from national and international corridors to provide strategic direction and guidance to move promising solutions through the product development value chain.

It will provide a holistic and integrated approach to strengthen and support the entire product development value chain for accelerating the research leads to product development. This will help not only in immediate product development for addressing public health needs, but also help to create an ecosystem which will facilitate development of a continuous pipeline of products.

The mission will concentrate on development of specific products such as vaccines, medical devices, biotherapeutics and diagnostics etc. Besides, it will also work on establishment of shared infrastructure and facilities. It will help in building and strengthening domain specific knowledge and management skills at the same time creating and enhancing technology transfer capabilities in public and private sector.


Gujarat government announces Biotechnology Policy 2016

Gujarat Government announced its ‘Biotechnology Policy-2016’ to establish state as a preferred destination for manufacturing of biotechnology products.

The policy has provisions for various incentives for investors who are keen to set up their units in the state. It aims to take annual turnover of biotechnology products to Rs 15,000 crore from current f Rs 4,500 crore turn over within next 3-4 years and make Gujarat top state in this sector in the country.

Under the policy
  • State government will provide capital subsidy up to Rs 25 crore on the total investment for developing a Biotechnology (BT) Park.
  • In addition, the developer of such park will be eligible for 100% reimbursement of stamp duty paid on lease or sale of the land for setting such park.
  • BT Park developer will also be given 100% reimbursement for electricity duty paid for a period of five years.
  • Capital subsidy up to Rs 10 per cent of the gross fixed capital investment(GFCI) with a ceiling of Rs 5 crore will be given to individual BT manufacturing units having GFCI up to Rs 50 crore.
  • Further, BT units borrowings up to Rs 50 crore will be entitled to an interest subsidy at the rate of 5% with a ceiling of 2.5 crore per annum.
  • Government would give 100% reimbursement of stamp duty paid on sale or lease of the land o encourage new start-ups in this sector.